IP Library Granted Patent US 11,654,054
Granted Patent B2
US 11,654,054 · App. 17/308,833 · Granted May 23, 2023

Photodisruptive laser fragmentation of tissue

Inventor: Ferenc Raksi (Mission Viejo, CA)
Assignee: Alcon Inc.
A61F9/00825A61F9/008A61F9/00736A61B2217/005A61F2009/0087A61F2009/00844A61F2009/00897
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,654,054
App. No.
17/308,833
Granted
May 23, 2023
Kind
B2
Abstract

An ophthalmic laser surgical system includes a pulsed laser source configured to generate a pulsed laser beam, optics configured to direct the laser beam towards a target region in a lens of an eye, and a processor configured to control the optics to form a regular array of cells in the target region by creating layers of photodisrupted bubbles to generate cell boundaries. The layers are created by causing the optics to scan the pulsed laser according to a curvature of a focal plane of the optics to track a natural curvature of the lens.

Claims (27)

1. An ophthalmic laser surgical system, comprising:

a pulsed laser source configured to generate a pulsed laser beam;

optics configured to direct the laser beam towards a target region in a lens of an eye, wherein the lens includes elongated fibers;

a processor configured to:

control the optics to form a laser pattern of a regular array of cells in the target region by creating layers of photodisrupted bubbles to generate cell boundaries and

control the optics to direct pulsed laser source to generate the laser pattern with a spot separation with a higher spot density and/or a higher laser pulse energy to form the cell boundaries that are perpendicular to the elongated fibers, as compared to when the cell boundaries are located parallel to the elongated fibers.

2. The system of claim 1 , wherein the regular array of cells are of a size suitable for extraction by aspiration without manual lens fragmentation.

3. The system of claim 1 , wherein a spatial extent of the regular array of cells is less than 340 microns.

4. The system of claim 1 , wherein the regular array of cells comprises cells with a size such that a ratio of a number of bubbles created to form the regular array of cells in the target region to a number of bubbles created to photodisrupt the same target region with a volumetric method is greater than 1:1.4.

5. The system of claim 1 , wherein the regular array of cells further comprises individual cells having walls that include photodisrupted bubbles to generate the cell boundaries.

6. The system of claim 5 , wherein the walls of individual cells include photodisrupted bubbles other than corner bubbles of the cell.

7. The system of claim 1 , wherein the regular array of cells includes a set of cells in a periodically repeating array.

8. An ophthalmic laser surgical system, comprising:

a pulsed laser source configured to generate a pulsed laser beam;

optics configured to direct the laser beam towards a target region in a lens of an eye, wherein the lens includes elongated fibers;

a processor configured to:

control the optics to form a laser pattern of a regular array of cells in the target region by creating layers of photodisrupted bubbles to generate cell boundaries, wherein the regular array of cells comprises individual cells having walls that include photodisrupted bubbles to generate the cell boundaries, and the walls of individual cells include photodisrupted bubbles other than corner bubbles of the cell; and

control the optics to direct the pulsed laser source to generate the laser pattern with a spot separation with a higher spot density and/or a higher laser pulse energy to form the cell boundaries that are perpendicular to the elongated fibers, as compared to when the cell boundaries are located parallel to the elongated fibers.

9. The system of claim 8 , wherein the regular array of cells are of a size suitable for extraction by aspiration without manual lens fragmentation.

10. The system of claim 8 , wherein a spatial extent of the regular array of cells is less than 340 microns.

11. The system of claim 8 , wherein the regular array of cells comprises cells with a size such that a ratio of a number of bubbles created to form the regular array of cells in the target region to a number of bubbles created to photodisrupt the same target region with a volumetric method is greater than 1:1.4.

12. The system of claim 8 , wherein the regular array of cells comprises cells with a size such that a ratio of a number of bubbles created to form the regular array of cells in the target region to a number of bubbles created to photodisrupt the same target region with a volumetric method is greater than 1:4.5.

13. The system of claim 8 , wherein the regular array of cells comprises cells with a size such that a ratio of the cell size to a bubble size is greater than 1:4.5.

14. The system of claim 8 , wherein the processor is configured to control the optics to form the bubbles with a spot separation of less than 20 microns.

15. The system of claim 8 , wherein the processor is configured to control the optics to reduce a linear speed of progression of a bubble placement at turning points smaller than a limiting value.

16. The system of claim 8 , wherein the processor is configured to control the optics to form curved layers.

17. The system of claim 8 , wherein the regular array of cells includes a set of cells in a periodically repeating array.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2021
From: RAKSI, FERENC
To: LENSX LASERS, INC.
Reel/Frame 056433/0736 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2021
From: ALCON LENSX, INC.
To: ALCON INC.
Reel/Frame 056433/0881 →
CHANGE OF NAME Recorded Jun 3, 2021
From: LENSX LASERS, INC.
To: ALCON LENSX, INC.
Reel/Frame 056476/0268 →
Continuity (5)
Continuation 15222730 · Jul 28, 2016
Continuation 14451881 · Aug 5, 2014
Continuation 12351784 · Jan 9, 2009
Provisional Application 61020115 · Jan 9, 2008
Related Publication 20210322219A1 · Oct 21, 2021